Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03065504 · ClinicalTrials.gov registry record · NA

Turmeric and Turmeric-containing Tablets and Sebum Production

A NA study of Skin Inflammation, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03065504 is a NA study of Skin Inflammation that has completed, run by University of California, Davis. The registered enrollment target is 30 participants, below the 45-participant average among 4 other Skin Inflammation trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03065504, a NA study of Skin Inflammation, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Turmeric
  • DIETARY_SUPPLEMENT Turmeric-containing combination tablet
  • DIETARY_SUPPLEMENT Placebo tablets

Study Locations (1)

California

  • University of California, Davis Dermatology Clinical Trials Unit - Sacramento

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-11
Est. Completion 2017-08-28
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03065504

The ClinicalTrials.gov registry entry for NCT03065504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 45-participant average among 4 other Skin Inflammation trials with a reported enrollment target (33% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Inflammation appearing as the primary indexed condition, and to 3 interventions - of which Turmeric is the first listed.

NCT03065504 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03065504 about?

NCT03065504 is a clinical study titled "Turmeric and Turmeric-containing Tablets and Sebum Production". A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects o...

What is the current status of trial NCT03065504?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2017-08-28.

What conditions does trial NCT03065504 study?

This clinical trial studies the following conditions: Skin Inflammation.

What interventions are being tested in trial NCT03065504?

The interventions under investigation include: Turmeric (DIETARY_SUPPLEMENT), Turmeric-containing combination tablet (DIETARY_SUPPLEMENT), Placebo tablets (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03065504?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03065504 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.